tiprankstipranks
Advertisement
Advertisement
Tenaya Therapeutics appoints Eric Hyllengren as CFO
PremiumThe FlyTenaya Therapeutics appoints Eric Hyllengren as CFO
2M ago
Zura Bio exceeds enrollment target in HS, SSc Phase 2 studies
Premium
The Fly
Zura Bio exceeds enrollment target in HS, SSc Phase 2 studies
2M ago
Zura Bio sees cash runway through the end of 2028
Premium
The Fly
Zura Bio sees cash runway through the end of 2028
2M ago
Zura Bio names Muzammil Mustufa chief business officer
PremiumThe FlyZura Bio names Muzammil Mustufa chief business officer
3M ago
Zura Bio reports Q1 EPS (22c) vs (19c) last year
Premium
The Fly
Zura Bio reports Q1 EPS (22c) vs (19c) last year
3M ago
Zura Bio Reports Q1 Results, Advances Phase 2 Programs
Premium
Company Announcements
Zura Bio Reports Q1 Results, Advances Phase 2 Programs
3M ago
Zura Bio reports FY25 EPS ($1.06) vs (60c) last year
PremiumThe FlyZura Bio reports FY25 EPS ($1.06) vs (60c) last year
5M ago
Zura Bio Updates Corporate Outlook on Lead Tibulizumab Program
Premium
Company Announcements
Zura Bio Updates Corporate Outlook on Lead Tibulizumab Program
5M ago
Zura Bio Highlights TibuSURE Phase 2 Trial Design
Premium
Company Announcements
Zura Bio Highlights TibuSURE Phase 2 Trial Design
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100